Afumigatus6abseracnc
A blood test that detects antibodies against Aspergillus fumigatus, a common fungus that can cause respiratory infections, especially in people with weakened immune systems.
{"Detects immune response to Aspergillus fumigatus fungus","Helps diagnose aspergillosis (fungal infection in lungs or other organs)","Important for patients with weakened immune systems, asthma, or COPD","Results show whether you have current or past exposure to the fungus","Results are interpreted together with symptoms and other test findings"}
Key facts at a glance
- LOINC
- 44440-6
- Short code
- A fumigatus6 Ab Ser-aCnc
- Synonyms
- A fumigatus6 Ab Ser-aCnc
- Category
- chemistry
- Sample
- serum
- Container
- Red-top tube (SST)
- Units
- N/A
- Fasting
- false
- Population
- adult
- Sex
- all
- Age range
- 18–65 years
- CPT
- 82784
- Specimen volume
- 5 mL
- Stability
- Room temperature: 4h, Refrigerated: 24h, Frozen: 7d
- Hemolysis max
- 500
- Lipemia max
- 1000
- Icterus max
- 500
- TAT
- 4–24 hours
- Order
- routine
What is this test?
The Aspergillus fumigatus antibody test is a blood test that looks for antibodies (IgG, IgM, and IgA) your immune system produces in response to Aspergillus fumigatus, a common mold found in soil, decaying plants, and indoor environments. This test helps determine if your body has been exposed to this fungus and mounted an immune response.
Why do I need this test?
Your doctor may order this test if you have symptoms of a respiratory infection that hasn't responded to antibiotics, especially if you have a weakened immune system due to conditions like HIV/AIDS, organ transplant, chemotherapy, or long-term steroid use. It is also used for patients with asthma or chronic obstructive pulmonary disease (COPD) who have worsening symptoms that might be caused by an fungal infection.
How is the test performed?
A healthcare professional will draw a small blood sample from a vein in your arm. The sample is then sent to a laboratory where it is tested for the presence and quantity of antibodies against Aspergillus fumigatus. You do not need to fast or make any special preparations before this test.
What do the results mean?
Results are typically reported as positive or negative, or as a titer (a measure of antibody concentration). A positive result indicates that you have been exposed to Aspergillus fumigatus and your immune system has produced antibodies. This could mean you have a current infection (especially with rising antibody levels) or had a past exposure. A negative result suggests no significant antibody response, but it does not completely rule out infection, especially in very early stages or in severely immunocompromised patients who may not produce adequate antibodies.
Are there any risks?
The risks associated with this blood test are minimal and include slight pain or bruising at the injection site, lightheadedness, and in rare cases, infection. These risks are generally minor and temporary.
Clinical interpretation
How abnormal results are interpreted and what conditions they suggest.
◆Associated findings2
Frequently asked questions
Who is at highest risk for Aspergillus infection?
Can I have a positive result without being sick?
How long does it take to get results?
Do I need to repeat the test?
Sources
- 1
- 2CDC - AspergillosisSource
- 3
Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy